Shingles Vaccine Linked to 9% Reduction in Cardiovascular Disease Risk

New research suggests that individuals who receive the Shingrix shingles vaccine may experience a 9% reduction in their cardiovascular burden over a seven-year period post-vaccination, compared to those who received an older shingles vaccine. This finding highlights a potential additional health benefit of the Shingrix vaccine.